VP of Research and Special Initiatives, Google
President and CEO of the Central Indiana Corporate Partnership
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many opportunities for scientists to create a customized program based on personal interests. New this year is “Epigenetic Inhibitor Discovery,” which nicely complements the most popular topics from previous years: Anti-Inflammatories, Protein-Protein Interactions, Macrocyclics and Constrained Peptides, Fragment-Based Drug Discovery, and Kinase Inhibitor Chemistry. More information and online registration is here.